ARTICLE | Company News
Cell Pathways other research news
May 28, 1996 7:00 AM UTC
At the meeting of the American Gastroenterological Association and the American Association for the Study of Liver Diseases in San Francisco, company researchers reported that there is a pathway separate from p53 that can induce apoptosis in either dividing or resting cancer cells.
Sulindac is a non-steroidal anti-inflammatory drug. Both its sulfide metabolite and FGN-1, a sulfone derivative, appear to induce apoptosis in tumor cells by a different pathway than p53, the researchers said. They showed that both sulindac sulfide and FGN-1 increased apoptosis in a HT-29 colon tumor cell line without altering the cells' expression of p53. Both also induced apoptosis in Saos-2 cells, which lack a functional p53 protein. ...